Sensible Biotechnologies
PrivateLast Round
Seed Round
Sep 2, 2026
Est. Valuation
$1.79M
Total Funding Raised
$21.68M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Sensible Biotechnologies is a biotechnology company that develops a cell-based platform for the design, optimization, and manufacturing of messenger RNA (mRNA).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sensible Biotechnologies Comparables
Compare Sensible Biotechnologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Waterfall Scientific | 82% | |
| Centillion Technology Limited | 81% | |
| NTxBio | 81% |
Sensible Biotechnologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Sep 2, 2026 | ||||
| Seed | Apr 9, 2024 | ||||
| Seed | Dec 1, 2023 | ||||
| Pre Seed | Apr 6, 2023 | ||||
| Accelerator | Aug 31, 2021 |
Sensible Biotechnologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Backed VC | Seed Round, Seed |
| Recode Health Ventures | Pre Seed |
| Recode Health Ventures | Pre Seed, Seed |
| KAYA | Seed Round, Seed |
| BlueYard Capital | Seed Round, Seed, Pre Seed |
| Amino Collective | Pre Seed |
| Onsight Ventures | Seed Round, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 2, 2026
$14M raised in Seed Round.
- Jul 17, 2026
Grew 36% QoQ, from 25 to 34 employees.
Sensible Biotechnologies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Sensible Biotechnologies's valuation, stock price, and market status.
Is Sensible Biotechnologies a public or private company?
Sensible Biotechnologies is a private company.
What is the current stock price of Sensible Biotechnologies?
Sensible Biotechnologies is a private company with no public stock price. No recent secondary market data is available.
How much is Sensible Biotechnologies worth (valuation)?
Valuation information for Sensible Biotechnologies is not publicly available.
Can I buy Sensible Biotechnologies stock?
Sensible Biotechnologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Sensible Biotechnologies's last funding round?
Sensible Biotechnologies's most recent funding round was Seed on December 1, 2023.
Who are the main investors in Sensible Biotechnologies?
Key investors in Sensible Biotechnologies include Recode Health Ventures, BlueYard Capital.
Will Sensible Biotechnologies IPO soon?
No public IPO plans have been announced for Sensible Biotechnologies.
How can I track Sensible Biotechnologies secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Sensible Biotechnologies's secondary market activity and sign up for updates.